This is therefore a comparing of the dividends, analyst recommendations, profitability, institutional ownership, risk, earnings and valuation in Epizyme Inc. (NASDAQ:EPZM) and Mersana Therapeutics Inc. (NASDAQ:MRSN). The two are both Biotechnology companies that compete with one another. Earnings and Valuation Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Epizyme Inc. 11 -0.19…
↧